CRL241220C210000
- 1.55
- 0.000.00%
Charles River Newsroom
Morgan Stanley Maintains Charles River(CRL.US) With Hold Rating, Cuts Target Price to $220
Cautious Hold Rating for Charles River Labs Amid Stable Projections and Slight Price Target Adjustment
Charles River Labs Is Maintained at Neutral by B of A Securities
Charles River Analyst Ratings
BofA Securities Maintains Charles River(CRL.US) With Hold Rating, Cuts Target Price to $210
Baird Maintains Charles River(CRL.US) With Hold Rating, Cuts Target Price to $197
Charles River Labs Is Maintained at Hold by TD Cowen
Charles River Analyst Ratings
TD Cowen Maintains Charles River(CRL.US) With Hold Rating, Maintains Target Price $227
TD Cowen Maintains Charles River(CRL.US) With Hold Rating, Raises Target Price to $227
Morgan Stanley Maintains Charles River(CRL.US) With Hold Rating, Maintains Target Price $225
Morgan Stanley Maintains Charles River(CRL.US) With Hold Rating, Raises Target Price to $225
J.P. Morgan Sticks to Its Hold Rating for Charles River Labs (CRL)
Hold Rating for Charles River Labs Amid Mixed Performance and Market Uncertainties
Baird Adjusts Charles River Laboratories International Price Target to $211 From $190, Maintains Neutral Rating
Charles River Labs Price Target Raised to $225.00/Share From $190.00 by Evercore ISI Group
Charles River Labs Is Maintained at In-Line by Evercore ISI Group
Charles River Analyst Ratings
UBS Maintains Charles River(CRL.US) With Buy Rating, Cuts Target Price to $250
Evercore Downgrades Charles River(CRL.US) to Hold Rating, Maintains Target Price $225